[1]. Kaplan GG, Ng SC. Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China. The lancet Gastroenterology & hepatology. 2016;1(4):307-16.
[2]. Ahuja V, Tandon RK. Inflammatory bowel disease in the Asia-Pacific area: a comparison with developed countries and regional differences. Journal of digestive diseases. 2010;11(3):134-47.
[3]. Kaplan GG, Ng SC. Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. Gastroenterology. 2017;152(2):313-21.e2.
[4]. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nature reviews Gastroenterology & hepatology. 2015;12(12):720-7.
[5]. Nishida A, Inoue R, Inatomi O, et al. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clinical journal of gastroenterology. 2018;11(1):1-10.
[6]. Bank S, Andersen PS, Burisch J, et al. Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort. PloS one. 2015;10(12):e0145302.
[7]. Verstockt B, Van Assche G, Vermeire S, et al. Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel disease. Expert opinion on biological therapy. 2017;17(1):31-47.
[8]. Kruis W, Nguyen PG, Morgenstern J. Promises and Dangers of Combination Therapy. Digestive diseases (Basel, Switzerland). 2017;35(1-2):56-60.
[9]. Wedrychowicz A, Zajac A, Tomasik P. Advances in nutritional therapy in inflammatory bowel diseases: Review. World journal of gastroenterology. 2016;22(3):1045-66.
[10]. Wang Y, Zhu J, DeLuca HF. Where is the vitamin D receptor? Archives of biochemistry and biophysics. 2012;523(1):123-33.
[11]. Matias-Guiu J, Oreja-Guevara C, Matias-Guiu JA, et al. Vitamin D and remyelination in multiple sclerosis. Neurologia (Barcelona, Spain). 2018;33(3):177-86.
[12]. Ahangar-Parvin R, Mohammadi-Kordkhayli M, Azizi SV, et al. The Modulatory Effects of Vitamin D on the Expression of IL-12 and TGF-beta in the Spinal Cord and Serum of Mice with Experimental Autoimmune Encephalomyelitis. Iranian journal of pathology. 2018;13(1):10-22.
[13]. Barbalho SM, Goulart RA, Gasparini RG. Associations between inflammatory bowel diseases and vitamin D. Critical reviews in food science and nutrition. 2019;59(8):1347-56.
[14]. Saponaro F, Marcocci C, Zucchi R. Vitamin D status and cardiovascular outcome. Journal of endocrinological investigation. 2019;42(11):1285-90.
[15]. Shang M, Sun J. Vitamin D/VDR, Probiotics, and Gastrointestinal Diseases. Current medicinal chemistry. 2017;24(9):876-87.
[16]. Francis I, AlAbdali N, Kapila K, et al. Vitamin D pathway related polymorphisms and vitamin D receptor expression in breast cancer. International journal for vitamin and nutrition research Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung Journal international de vitaminologie et de nutrition. 2019:1-9.
[17]. Bakke D, Sun J. Ancient Nuclear Receptor VDR With New Functions: Microbiome and Inflammation. Inflammatory bowel diseases. 2018;24(6):1149-54.
[18]. Ramagopalan SV, Heger A, Berlanga AJ, et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome research. 2010;20(10):1352-60.
[19]. Laverny G, Penna G, Vetrano S, et al. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease. Immunology letters. 2010;131(1):49-58.
[20]. Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Reviews in endocrine & metabolic disorders. 2017;18(2):153-65.
[21]. Stein AC, Gaetano JN, Jacobs J, et al. Northern Latitude but Not Season Is Associated with Increased Rates of Hospitalizations Related to Inflammatory Bowel Disease: Results of a Multi-Year Analysis of a National Cohort. PloS one. 2016;11(8):e0161523.
[22]. Bora S, Cantorna MT. The role of UVR and vitamin D on T cells and inflammatory bowel disease. Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology. 2017;16(3):347-53.
[23]. Sun PL, Zhang S. Correlations of 25-hydroxyvitamin D3 level in patients with ulcerative colitis with inflammation level, immunity and disease activity. European review for medical and pharmacological sciences. 2018;22(17):5635-9.
[24]. Groves NJ, Kesby JP, Eyles DW, et al. Adult vitamin D deficiency leads to behavioural and brain neurochemical alterations in C57BL/6J and BALB/c mice. Behavioural brain research. 2013;241:120-31.
[25]. Gupta A, Aslam M, Rathi S, et al. Association of Vitamin D Levels and type 2 Diabetes Mellitus in Asian Indians is Independent of Obesity. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. 2018;126(9):553-8.
[26]. Balden R, Selvamani A, Sohrabji F. Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats. Endocrinology. 2012;153(5):2420-35.
[27]. Ulitsky A, Ananthakrishnan AN, Naik A, et al. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN Journal of parenteral and enteral nutrition. 2011;35(3):308-16.
[28]. Ananthakrishnan AN, Khalili H, Higuchi LM, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology. 2012;142(3):482-9.
[29]. Norman AW, Bouillon R. Vitamin D nutritional policy needs a vision for the future. Experimental biology and medicine (Maywood, NJ). 2010;235(9):1034-45.
[30]. Herrero-Fresno A, Olsen JE. Salmonella Typhimurium metabolism affects virulence in the host - A mini-review. Food microbiology. 2018;71:98-110.
[31]. Mizoguchi A, Yano A, Himuro H, et al. Clinical importance of IL-22 cascade in IBD. Journal of gastroenterology. 2018;53(4):465-74.
[32]. Barthel M, Hapfelmeier S, Quintanilla-Martinez L, et al. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infection and immunity. 2003;71(5):2839-58.
[33]. Caceres F, Castanon M, Lerena J, et al. [Mesenteric flow in an experimental model of ischaemia-reperfusion in rats]. Anales de pediatria (Barcelona, Spain : 2003). 2014;80(3):151-8.
[34]. Bergstrom KS, Kissoon-Singh V, Gibson DL, et al. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS pathogens. 2010;6(5):e1000902.
[35]. Sarbagili-Shabat C, Sigall-Boneh R, Levine A. Nutritional therapy in inflammatory bowel disease. Current opinion in gastroenterology. 2015;31(4):303-8.
[36]. Zhao H, Zhang H, Wu H, et al. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice. BMC gastroenterology. 2012;12:57.
[37]. Cantorna MT, Munsick C, Bemiss C, et al. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. The Journal of nutrition. 2000;130(11):2648-52.
[38]. Ooi JH, Li Y, Rogers CJ, et al. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. The Journal of nutrition. 2013;143(10):1679-86.
[39]. Ryz NR, Patterson SJ, Zhang Y, et al. Active vitamin D (1,25-dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses. American journal of physiology Gastrointestinal and liver physiology. 2012;303(12):G1299-311.
[40]. Issa CM. Vitamin D and Type 2 Diabetes Mellitus. Advances in experimental medicine and biology. 2017;996:193-205.
[41]. Tabatabaeizadeh SA, Tafazoli N, Ferns GA, et al. Vitamin D, the gut microbiome and inflammatory bowel disease. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences. 2018;23:75.
[42]. Pierrot-Deseilligny C, Souberbielle JC. Vitamin D and multiple sclerosis: An update. Multiple sclerosis and related disorders. 2017;14:35-45.
[43]. Heikkinen S, Vaisanen S, Pehkonen P, et al. Nuclear hormone 1alpha,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic acids research. 2011;39(21):9181-93.
[44]. Kongsbak M, von Essen MR, Boding L, et al. Vitamin D up-regulates the vitamin D receptor by protecting it from proteasomal degradation in human CD4+ T cells. PloS one. 2014;9(5):e96695.
[45]. Barbachano A, Fernandez-Barral A, Ferrer-Mayorga G, et al. The endocrine vitamin D system in the gut. Molecular and cellular endocrinology. 2017;453:79-87.
[46]. Christakos S, Dhawan P, Verstuyf A, et al. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiological reviews. 2016;96(1):365-408.
[47]. Wang J, Thingholm LB, Skieceviciene J, et al. Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota. Nature genetics. 2016;48(11):1396-406.
[48]. Wu S, Zhang YG, Lu R, et al. Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis. Gut. 2015;64(7):1082-94.
[49]. Jin D, Wu S, Zhang YG, et al. Lack of Vitamin D Receptor Causes Dysbiosis and Changes the Functions of the Murine Intestinal Microbiome. Clinical therapeutics. 2015;37(5):996-1009.e7.
[50]. Reinoso Webb C, Koboziev I, Furr KL, et al. Protective and pro-inflammatory roles of intestinal bacteria. Pathophysiology : the official journal of the International Society for Pathophysiology. 2016;23(2):67-80.
[51]. Loh G, Blaut M. Role of commensal gut bacteria in inflammatory bowel diseases. Gut microbes. 2012;3(6):544-55.
[52]. Herikstad H, Motarjemi Y, Tauxe RV. Salmonella surveillance: a global survey of public health serotyping. Epidemiology and infection. 2002;129(1):1-8.
[53]. Ferreira RB, Gill N, Willing BP, et al. The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization. PloS one. 2011;6(5):e20338.
[54]. Gradel KO, Nielsen HL, Schonheyder HC, et al. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology. 2009;137(2):495-501.